With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.7787-70-4,Copper(I) bromide,as a common compound, the synthetic route is as follows.
7787-70-4, Compound 2 (23mg, 0.05mmol) in dichloromethane (2mL) was slowly added on a solution of copper bromide (7.2mg, 0.05mmol) in acetonitrile (2mL) at-60C. The orange-red solution resulting from complete diffusion was slowly evaporated at r.t. to afford compound 6 (quantitative yield) as colorless crystals suitable for an X-ray diffraction analysis. Mp=93C. 1H NMR (CDCl3, 300MHz): delta 5.21 (s, 4H, =CH2), 4.30-3.95 (m, 8H, CH2-C=), 4.00-2.35 (m, 24H). Br2C20Cu2H36O4S4 (755.56): calcd C 31.79, H, 4.80; found: C 31.09, H, 4.22.
The synthetic route of 7787-70-4 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Carel, Guillaume; Madec, David; Saponar, Alina; Saffon, Nathalie; Nemes, Gabriela; Rima, Ghassoub; Castel, Annie; Journal of Organometallic Chemistry; vol. 755; (2014); p. 72 – 77;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”